Both in Pharmaceuticals
Maravai LifeSciences Holdings vs Harrow
Over the past year MRVI returned +171.3% and HROW returned −17.4%; their daily moves had a correlation of 0.24.
MRVI +171.3% HROW −17.4%Growth of $1, one year, split-adjusted
| Metric | MRVI | HROW |
|---|---|---|
| Price | $7.79 | $29.15 |
| Market cap | $1.16B | $1.09B |
| Today | +4.50% | +2.14% |
| 1 month | −0.8% | −4.0% |
| 6 months | +97.6% | −27.6% |
| Year to date | +139.5% | −40.5% |
| 1 year | +164.8% | −18.9% |
| Revenue growth (YoY) | +8.5% | +10.9% |
| Gross margin | 40.1% | 71.3% |
| Net margin | −24.1% | −24.4% |
| P/E (TTM) | — | — |
| Price / sales | 5.6× | 4.0× |
| Net cash | -$106.6M | -$208.5M |
| Dividend yield | — | — |
| Volatility (60d) | 86.4% | 40.2% |
| Short % of float | 10.7% | 24.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).